Advertisement
Singapore markets closed

  • Straits Times Index

    3,332.80
    -10.55 (-0.32%)
     

  • Nikkei

    39,583.08
    +241.54 (+0.61%)
     

  • Hang Seng

    17,718.61
    +2.14 (+0.01%)
     

  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     

  • Bitcoin USD

    60,706.54
    +70.32 (+0.12%)
     

  • CMC Crypto 200

    1,262.46
    -21.37 (-1.66%)
     

  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     

  • Dow

    39,118.86
    -45.20 (-0.12%)
     

  • Nasdaq

    17,732.60
    -126.08 (-0.71%)
     

  • Gold

    2,336.90
    +0.30 (+0.01%)
     

  • Crude Oil

    81.46
    -0.28 (-0.34%)
     

  • 10-Yr Bond

    4.3430
    +0.0550 (+1.28%)
     

  • FTSE Bursa Malaysia

    1,590.09
    +5.15 (+0.32%)
     

  • Jakarta Composite Index

    7,063.58
    +95.63 (+1.37%)
     

  • PSE Index

    6,411.91
    +21.33 (+0.33%)
     

Here's What Key Metrics Tell Us About Walgreens (WBA) Q3 Earnings

Zacks Equity Research
·2-min read

Walgreens Boots Alliance (WBA) reported $36.35 billion in revenue for the quarter ended May 2024, representing a year-over-year increase of 2.6%. EPS of $0.63 for the same period compares to $1.00 a year ago.

The reported revenue represents a surprise of +1.07% over the Zacks Consensus Estimate of $35.96 billion. With the consensus EPS estimate being $0.67, the EPS surprise was -5.97%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how Walgreens performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenues- U.S. Retail Pharmacy: $28.50 billion compared to the $27.89 billion average estimate based on five analysts. The reported number represents a change of +2.3% year over year.

  • Revenues- U.S. Healthcare: $2.13 billion compared to the $2.12 billion average estimate based on five analysts. The reported number represents a change of +7.6% year over year.

  • Revenues- International: $5.73 billion versus $5.74 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +2.8% change.

  • Adjusted operating income (loss)- U.S. Retail Pharmacy: $501 million versus $620.19 million estimated by four analysts on average.

  • Adjusted operating income (loss)- Corporate and Other: -$42 million versus -$57.38 million estimated by four analysts on average.

  • Adjusted operating income (loss)- U.S. Healthcare: -$22 million versus -$48.35 million estimated by four analysts on average.

  • Adjusted operating income (loss)- International: $175 million versus the four-analyst average estimate of $190.99 million.

View all Key Company Metrics for Walgreens here>>>

Shares of Walgreens have returned +5.2% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Walgreens Boots Alliance, Inc. (WBA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research